← All stories
Markets
Revolution’s lifesaving pancreatic cancer drug wins speedy FDA approval
2 outlets - including Investing and Biopharmadive - are covering this story. Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly lucrative drug launch.
Covered by 2 outlets
All coverage · 2 articles
Investing.com Stock Market
·3h ago
Revolution’s lifesaving pancreatic cancer drug wins speedy FDA approval
BioPharma Dive
·3h ago
Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA
Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly lucrative drug launch.